Literature DB >> 34116972

Vaccinations in patients with inflammatory bowel disease.

Fabio Salvatore Macaluso1, Giuseppina Liguori2, Massimo Galli3.   

Abstract

Treatment of inflammatory bowel disease (IBD) frequently requires administration of immunosuppressive therapies, which increases susceptibility to a number of infectious pathogens. However, many infections can be prevented by correct and appropriate utilization of vaccinations. While several guidelines have been published on vaccination schedules in patients with IBD, vaccination rates remain suboptimal and even lower than those in the general population. This is due to many factors including poor awareness of the importance of vaccines by gastroenterologists and general practitioners as well as potential prejudices of patients regarding the safety and benefits of vaccines. With the aim of increasing awareness about the key role of immunization in the management of patients with IBD, the present review examines the existing literature relating to the main vaccinations and their application in these patients. We also summarize current evidence in order to provide clinicians with an easy source of reference for the principal recommendations for prevention of infectious diseases in patients with IBD. In addition, the recommendations about traveling for IBD patients are briefly explored. Lastly, since it is important for gastroenterologists to be aware of recommendations on vaccination, we recommend implementing educational programs to ensure compliance with current guidelines.
Copyright © 2021. Published by Elsevier Ltd.

Entities:  

Keywords:  Crohn's disease; Immunosuppression; Inflammatory bowel disease; Ulcerative colitis; Vaccination

Mesh:

Substances:

Year:  2021        PMID: 34116972     DOI: 10.1016/j.dld.2021.05.015

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  2 in total

1.  SARS-CoV-2-inactivated vaccine hesitancy and the safety in inflammatory bowel disease patients: a single-center study.

Authors:  Yubin Cao; Jiaming Feng; Shihao Duan; Yi Yang; Yan Zhang
Journal:  Therap Adv Gastroenterol       Date:  2022-06-11       Impact factor: 4.802

2.  Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study.

Authors:  Fabio Salvatore Macaluso; Mariabeatrice Principi; Federica Facciotti; Antonella Contaldo; Alessia Todeschini; Simone Saibeni; Cristina Bezzio; Fabiana Castiglione; Olga Maria Nardone; Rocco Spagnuolo; Massimo Claudio Fantini; Gaia Riguccio; Flavio Caprioli; Chiara Viganò; Carla Felice; Gionata Fiorino; Carmen Correale; Giorgia Bodini; Monica Milla; Giulia Scardino; Marta Vernero; Federico Desideri; Mariella Mannino; Giuseppe Rizzo; Ambrogio Orlando
Journal:  Dig Liver Dis       Date:  2022-08-29       Impact factor: 5.165

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.